Alkylation of Cyclohexanecarboxylic Acid for Pharmaceutical Intermediates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid as an intermediate in pharmaceutical synthesis are inefficient, requiring multiple steps and low yields, and lack a streamlined process for purification and reaction conditions.
Innovation Solution
A process involving the reaction of cyclohexanecarboxylic acid with an alkylating agent in the presence of a secondary amine and alkyllithium, followed by halogenation and acylation steps, using specific solvents and conditions to optimize yield and purity, such as using sodium methoxide and tetrahydrofuran, and purifying with an aqueous solution of controlled pH.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current methods are used for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid, then the synthesis can be performed with existing procedures, but the yield is low and multiple steps are required
Solution Approach 1:
The patent combines multiple reaction steps into a one-pot synthesis procedure. The alkylation reaction of cyclohexanecarboxylic acid with 1-halo-2-ethylbutane is performed in the presence of a secondary amine and alkyllithium, followed by halogenation and acylation steps all in the same reaction vessel, eliminating the need for separate purification and re-setup steps between reactions.
Solution Approach 2:
The patent employs preliminary formation of the cyclohexanecarboxylic acid salt with an alkali metal before the alkylation step. This pre-preparation of the reactive species enables the subsequent alkylation to proceed more efficiently and sets up the reaction conditions for the cascade of transformations that follow.
2Manufacturing precision
If current purification methods are used, then the product can be obtained, but the purity is insufficient and by-products are present
Solution Approach 1:
The patent utilizes pH control as a critical parameter to manage the reaction and purification process. The secondary amine and controlled pH conditions during the reaction minimize unwanted side reactions, while the final purification step uses pH adjustment to selectively precipitate or extract the desired product from by-products, achieving high purity without extensive chromatography.
3Productivity
If the reaction is performed without optimized conditions, then the procedure is simpler, but the yield and purity are compromised
Solution Approach 1:
The patent optimizes several reaction parameters simultaneously: the choice of secondary amine base, the equivalent ratio of alkyllithium (1.05-1.2 equivalents), the solvent system (tetrahydrofuran), and temperature control. These parameter optimizations work together to enable high yielding reactions under practical manufacturing conditions.
Solution Approach 2:
The secondary amine serves as an intermediary species in the reaction mechanism, facilitating the alkylation process and enabling the cascade reactions to proceed through stable intermediates. This intermediary role allows the reaction to proceed under milder conditions with higher selectivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process significantly improves the yield and purity of 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid, achieving high content and reducing the presence of by-products, thereby enhancing the efficiency of pharmaceutical intermediate production.
Implementation Method 1
reacting cyclohexanecarboxylic acid derivative of formula (II) wherein Y is an alkali metal, with an alkylating agent such as a 1-halo-2-ethylbutane or a sulfonate ester of 2-ethyl-1-butanol, in the presence of a secondary amine and (C1-C6)alkyllithium
Implementation Method 2
purifying the compound of formula (I) by extraction with an aqueous solution with a pH in the range of 7.5-11
Data Source
AI summary
The present invention relates to a process for the preparation of 1 -(2-cthyl-butyl)-cyclohexanecarboxylic acid which is useful as an intermediate in the preparation of, pharmaceutical active compounds, comprising reacting cyclohexanecarboxylic acid derivative of formula (II) wherein Y is an alkali metal, with an alkylating agent, in the presence of a secondary amine and (C1-C6)alkyllithium, (C3-C6)cycloalkyllithium or phenyllithium.